Skip to main content
Signal8

enVVeno Medical to Showcase the enVVe System at 38th Annual Transcatheter Cardiovascular Therapeutics (TCT) Scientific Symposium

$NVNOPress releaseNov 2, 2026, 8:43 AM ETRead the release

enVVeno Medical will present its investigational enVVe System at the 38th annual TCT Scientific Symposium in San Diego on November 2, 2026. CEO Rob Berman will deliver the presentation during the Innovation in Endovascular Therapies session, introducing the transcatheter venous valve to a global audience of cardiovascular specialists.

Key figures

Tct attendees
10,000+ physicians, researchers, investors and healthcare leaders
Dvi us patients estimated
3 million

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    NVNO: enVVeno Medical to Showcase the enVVe System at 38th Annual Transcatheter Cardiovascular Therapeutics (TCT) Scientific Symposium — AI Analysis | Signal8